| Aug 16 |
Nuntius partners with Taiho to develop mRNA cancer therapies
|
| Aug 10 |
Arcus Biosciences Second Quarter 2024 Earnings: Beats Expectations
|
| Aug 10 |
We're Not Very Worried About Arcus Biosciences' (NYSE:RCUS) Cash Burn Rate
|
| Aug 9 |
Arcus Biosciences: Getting Too Cheap To Ignore (Reiterate Buy)
|
| Aug 9 |
Arcus Biosciences, Inc. (RCUS) Q2 2024 Earnings Call Transcript
|
| Aug 9 |
Arcus Biosciences, Inc. 2024 Q2 - Results - Earnings Call Presentation
|
| Aug 9 |
Arcus Biosciences GAAP EPS of -$1.02 beats by $0.11, revenue of $39M beats by $12.51M
|
| Aug 8 |
Arcus Biosciences, Inc. (RCUS) Reports Q2 Loss, Tops Revenue Estimates
|
| Aug 8 |
Arcus Biosciences Reports Second-Quarter 2024 Financial Results and Provides a Pipeline Update
|
| Aug 7 |
Arcus Biosciences Q2 2024 Earnings Preview
|
